Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy.
Saved in:
| Title: | Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy. |
|---|---|
| Authors: | Hucke A; Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.; Institute of Physiology I, University of Münster, 48149 Münster, Germany., Kantauskaite M; Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany.; Klinik für Nephrologie, Universitätsklinikum Düsseldorf, 40225 Düsseldorf, Germany., Köpp TN; Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany., Wehe CA; Institute of Inorganic and Analytical Chemistry, University of Münster, 48149 Münster, Germany., Karst U; Institute of Inorganic and Analytical Chemistry, University of Münster, 48149 Münster, Germany., Nedvetsky PI; Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany., Ciarimboli G; Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2024 Mar 02; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
